GMN-24806-58487
2 vaccinations
4 coded responses
25 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 61-65
- ZIP prefix
- 493 / MI
- Registered
- 2021-03-16
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-16
Registered in v-safe
-
2021-03-16
Dose 1 — Pfizer-BioNTech
- 2021-03-16
- 2021-03-17
- 2021-03-18
-
2021-03-19
Health check-in — days 1–6 daily, dose 1Feeling: Good · Headache, Fatigue or tirednessAdult check-in
- 2021-03-20
- 2021-03-21
- 2021-03-22
- 2021-03-24
- 2021-03-30
-
2021-04-06
Dose 2 — Pfizer-BioNTech
- 2021-04-06
-
2021-04-07
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to workAdult check-in
-
2021-04-08
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Swelling · Fever · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend schoolAdult check-in
-
2021-04-09
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: FairFree text: Swollen lymph node in injection side armpitMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-10
Survey response — days 1–6 daily, dose 2MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Fair · Headache, Fatigue or tirednessFree text: Still swelling in armpit lymph node. Less tender.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-11
Survey response — days 1–6 daily, dose 2MedDRA: Lymph node pain, Lymphadenopathy — Feeling: GoodFree text: Armpit lymph node still shrinking. No longer sore.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-12
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
- 2021-04-14
- 2021-04-20
- 2021-04-27
- 2021-05-04
- 2021-05-11
- 2021-05-18
- 2021-07-06
- 2021-10-05
-
2022-04-06
Survey response — 12 months, dose 2MedDRA: Haemoglobin decreased, Hysterectomy, Transfusion, Uterine dilation and curettage — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, HospitalizationFree text: Transfusion for low hemoglobin; vaginal ultrasound; D&C and tissue biopsy; and finally a complete hysterectomy.MedDRA releases: 2024-11 · check-in free text available
-
2022-04-06
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · Hospitalization · 1 call case(s)
- 2022-04-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-16 | Pfizer-BioNTech | |
| 2 | 2021-04-06 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-04-06 | Unsuccessful |
Free text
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): Swollen lymph node in injection side armpit
Systemic reaction (other): Still swelling in armpit lymph node. Less tender.
Systemic reaction (other): Armpit lymph node still shrinking. No longer sore.
Release 11 — 12 months, dose 2
Symptoms: Transfusion for low hemoglobin; vaginal ultrasound; D&C and tissue biopsy; and finally a complete hysterectomy.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Haemoglobin decreased | · | · | ✓ |
| SD | Hysterectomy | · | · | ✓ |
| SD | Transfusion | · | · | ✓ |
| SD | Uterine dilation and curettage | · | · | ✓ |
| SRO | Lymph node pain | ✓ | ✓ | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release